99% Purity Erdafitinib Powder FGFR Inhibitor with Custom Packaging for Research and Development

Product Overview

Erdafitinib, identified by CAS No. 1346242-81-6, is a small-molecule chemical compound with the molecular formula C25H30N6O2. It is known for its activity as a fibroblast growth factor receptor (FGFR) inhibitor and is associated with research into FGFR signaling pathways.

FGFR signaling is involved in several biological processes, including cell growth, differentiation, and cellular communication. Because alterations in these pathways have been studied in different biological systems, Erdafitinib has become a compound of interest in molecular biology and pharmaceutical research.

The product described here is supplied as a white powder, with a stated purity of greater than 99%. HPLC-UV is the specified analytical method. These details provide a starting point for technical evaluation and supplier comparison. Buyers should review the relevant batch documentation to verify the identity, purity, and quality specifications of the material.

Whether you are reviewing chemical reference information, comparing material specifications, or sourcing compounds for an appropriate research and development project, accurate product identification and supporting documentation are important considerations.

Erdafitinib Product Specifications

Key Product Characteristics

Defined Chemical Identity

Erdafitinib is identified by its CAS number, 1346242-81-6, and molecular formula, C25H30N6O2. These identifiers help researchers and procurement teams verify product information and distinguish the compound from other chemical materials.

When sourcing a chemical compound, confirming the CAS number and molecular formula is an important first step. Buyers should also review the available analytical documentation before making a final purchasing decision.

Specified Purity and Analytical Testing

The stated purity specification for this Erdafitinib powder is greater than 99%. HPLC-UV is listed as the analytical test method.

High-performance liquid chromatography with ultraviolet detection is used to separate and analyze compounds with suitable UV absorption characteristics. The actual analytical procedure, reference standard, and acceptance criteria should be reviewed alongside the relevant batch report.

Purity figures should be interpreted in the context of the test method and supporting documentation. For this reason, buyers are encouraged to request the available batch-specific quality information when evaluating the material.

White Powder Form

The product is described as a white powder. Appearance is a useful preliminary characteristic for material inspection, but it does not independently establish chemical identity, purity, or suitability for a particular application. Appropriate analytical testing remains important.

Flexible Packaging Options

Several package sizes are listed, including 1 g, 100 g, 1 kg, and 25 kg. Packaging availability depends on the requested quantity, product form, and applicable handling requirements.

For smaller quantities, buyers may inquire about sample availability and suitable packaging. Larger orders can be discussed individually to confirm packaging arrangements, supply capacity, and estimated lead time.

Research Background and Potential Applications

Erdafitinib is associated with the inhibition of fibroblast growth factor receptors, commonly referred to as FGFRs. These receptors participate in signaling networks that regulate various cellular activities.

FGFR-related pathways have been investigated in molecular and biomedical research, including studies of receptor signaling and its relationship to cellular behavior. Erdafitinib is therefore relevant to the broader scientific literature concerning FGFR-targeted compounds.

Its established pharmacological background also makes it a subject of interest in pharmaceutical research . However, the suitability of any supplied material depends on its verified grade, quality documentation, and intended use.

This product description is intended to provide chemical identification and sourcing information. It does not establish that the material is suitable for clinical use, human administration, or any specific formulation. Buyers are responsible for ensuring that procurement and use comply with applicable laws and regulations.

Packaging, Handling, and Storage

Packaging should be selected according to the required quantity and appropriate material-handling conditions. Available formats listed in the product information include bags and drums in several sizes.

The original specifications indicate storage at 2–8°C, protected from light and kept sealed. Before establishing storage procedures, buyers should verify the recommended temperature, moisture protection requirements, and other handling conditions against the applicable technical documentation.

Keep the container properly closed and clearly labeled. Avoid exposure to unsuitable environmental conditions, and follow the relevant safety data and handling instructions.

The retest period should be confirmed using appropriate stability data and product-specific documentation. A two-year period should not be treated as universally validated unless supported by the relevant records.

Ordering and Supply Information

For purchasing inquiries, buyers can provide the requested quantity, preferred package size, destination country, and documentation requirements. This information helps determine availability, packaging suitability, and the estimated delivery schedule.

The stated lead time is 5–10 days, subject to order confirmation, stock status, and shipping arrangements. Air and sea shipping options may be available depending on the destination, carrier acceptance, and applicable transport requirements.

Sample requests and customized packaging can be discussed before ordering. Buyers should confirm the final quotation, product specifications, applicable documentation, and delivery conditions before proceeding.

For batch-specific information, please contact our team with your requirements so that the relevant details can be checked.

Frequently Asked Questions

The CAS number listed for Erdafitinib is 1346242-81-6.

The molecular formula is C25H30N6O2.

The supplied specification describes it as a white powder.

The stated purity is greater than 99%. The exact batch result should be verified using the relevant analytical documentation.

HPLC-UV is the specified analytical method.

Listed package sizes include 1 g, 100 g, 1 kg, and 25 kg, subject to confirmation of availability and packaging suitability.

The original product information lists storage at 2–8°C, protected from light and kept sealed. Confirm the applicable conditions against product-specific documentation before storage.

Provide the required quantity, preferred package size, destination country, and any documentation requirements. Availability and delivery arrangements can then be reviewed.

Conclusion

Erdafitinib CAS 1346242-81-6 is identified by the molecular formula C25H30N6O2 and is described as a white powder with a stated purity greater than 99%. The listed analytical method is HPLC-UV, and multiple package sizes may be available upon confirmation.

For accurate material evaluation, buyers should review batch-specific analytical information, verify storage recommendations, and confirm packaging and shipping arrangements before placing an order.